New Mexico Pauses Johnson & Johnson COVID Vaccine

NMDOH Secretary Dr. Tracie Collins


SANTA FE – The New Mexico Department of Health (NMDOH) announced Tuesday that Johnson & Johnson (J&J) COVID-19 vaccine distribution will be paused following federal Centers for Disease Control (CDC) and Food and Drug Administration (FDA) recommendations.

These announcements follow reports of six “rare and severe” blood clots – out of 6.8 million doses given – among women between the ages of 18 and 48 in the United States. Symptoms occurred 6 to 13 days after vaccination.

“New Mexico – like the federal government – is acting out of an abundance of caution,” NMDOH Secretary Dr. Tracie Collins said. “As we learn more, we will share that information.”

Scheduled J&J events and vaccinations will be paused or shifted to Pfizer and Moderna.

People who have received the J&J vaccine who develop severe headache, blurred vision, seizure, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

Health care providers should report adverse events to the Vaccine Adverse Events Reporting System at Note: these adverse events are extremely rare – less than one per million.